Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 2Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Carcinoma, Hepatocellular 14Carcinoma, Non-Small-Cell Lung 9Colorectal Neoplasms 7Stomach Neoplasms 6Triple Negative Breast Neoplasms 5Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Neoplasms 3Melanoma 3Urinary Bladder Neoplasms 2Recurrence 2Rectal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Extranodal NK-T-Cell 2Liver Neoplasms 2Glioblastoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Advanced Biliary Tract Cancer 2Urothelial Carcinoma Bladder 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Radiation Pneumonitis 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × tislelizumab × Clear all
NCT04734262 2023-11-18

SPARK

Fudan University

Phase 2 Unknown
98 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05861635 2023-05-17

The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 4 Unknown
42 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡